Farringdon Capital’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$302K Sell
3,565
-8,498
-70% -$685K 0.15% 100
2026
Q1
$853K Sell
12,063
-2,168
-15% -$162K 0.19% 152
2025
Q4
$1.12M Buy
+14,231
New +$1.13M 0.28% 105
2025
Q3
Sell
-17,624
Closed -$1.42M 582
2025
Q2
$1.42M Buy
17,624
+11,633
+194% +$898K 0.48% 36
2025
Q1
$481K Buy
5,991
+623
+12% +$51.8K 0.24% 109
2024
Q4
$440K Buy
+5,368
New +$447K 0.18% 161

Other funds holding MET

Farringdon Capital's MET Position: Q2 2026 in Review

Farringdon Capital reduced its MetLife (MET) stake by 70% in Q2 2026, selling an estimated $685K and leaving 3,565 shares worth $302K. The position accounts for 0.15% of the portfolio, ranked #100.

Farringdon Capital first reported a position in MET in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.42M in Q2 2025. 1,445 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Farringdon Capital held 3,565 shares of MetLife worth $302K as of Q2 2026.
  • Farringdon Capital sold 8,498 MetLife shares in Q2 2026, an estimated $685K.
  • MetLife made up 0.15% of Farringdon Capital's portfolio in Q2 2026, its #100 holding.
  • Farringdon Capital first reported a position in MetLife in Q4 2024 and has held it in 6 quarters since.
  • Farringdon Capital's MetLife position peaked at $1.42M in Q2 2025.
  • 1,445 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Farringdon Capital's 13F filing for Q2 2026, filed 12 Aug 2026.